1
|
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.
|
Cancer Cell
|
2005
|
3.74
|
2
|
Exogenous control of mammalian gene expression through modulation of RNA self-cleavage.
|
Nature
|
2004
|
2.48
|
3
|
The mouse cornea micropocket angiogenesis assay.
|
Nat Protoc
|
2007
|
1.74
|
4
|
Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells.
|
FASEB J
|
2006
|
1.52
|
5
|
Forty-year journey of angiogenesis translational research.
|
Sci Transl Med
|
2011
|
1.51
|
6
|
S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.
|
Cancer Res
|
2002
|
1.28
|
7
|
An orally delivered small-molecule formulation with antiangiogenic and anticancer activity.
|
Nat Biotechnol
|
2008
|
1.19
|
8
|
2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.
|
Am J Pathol
|
2008
|
1.14
|
9
|
The effect of genetic diversity on angiogenesis.
|
Exp Cell Res
|
2006
|
1.13
|
10
|
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients.
|
Angiogenesis
|
2012
|
1.12
|
11
|
Genetic loci that control vascular endothelial growth factor-induced angiogenesis.
|
FASEB J
|
2003
|
1.10
|
12
|
Endostatin inhibits the growth of endometriotic lesions but does not affect fertility.
|
Fertil Steril
|
2005
|
1.08
|
13
|
Angiogenesis in wounds treated by microdeformational wound therapy.
|
Ann Surg
|
2011
|
1.05
|
14
|
A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.
|
Am J Pathol
|
2006
|
1.03
|
15
|
Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.
|
Cancer Res
|
2007
|
1.03
|
16
|
Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis.
|
FASEB J
|
2007
|
1.02
|
17
|
Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution.
|
Cancer Res
|
2007
|
1.02
|
18
|
Angiogenesis and antiangiogenic therapy in endometriosis.
|
Microvasc Res
|
2007
|
1.02
|
19
|
Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model.
|
Fertil Steril
|
2006
|
1.01
|
20
|
Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment.
|
J Clin Invest
|
2013
|
0.99
|
21
|
Genetic loci that control the angiogenic response to basic fibroblast growth factor.
|
FASEB J
|
2004
|
0.97
|
22
|
Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy.
|
FASEB J
|
2002
|
0.96
|
23
|
Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs.
|
Invest Ophthalmol Vis Sci
|
2008
|
0.95
|
24
|
Dendritic cells augment choroidal neovascularization.
|
Invest Ophthalmol Vis Sci
|
2008
|
0.94
|
25
|
Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis.
|
Am J Pathol
|
2011
|
0.93
|
26
|
Genetic loci that control the size of laser-induced choroidal neovascularization.
|
FASEB J
|
2009
|
0.89
|
27
|
Antiangiogenic effect of oral 2-methoxyestradiol on choroidal neovascularization in mice.
|
Exp Eye Res
|
2006
|
0.89
|
28
|
Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model.
|
Fertil Steril
|
2005
|
0.87
|
29
|
The classical pink-eyed dilution mutation affects angiogenic responsiveness.
|
PLoS One
|
2012
|
0.86
|
30
|
Injection of antiangiogenic agents into the macaque preovulatory follicle: disruption of corpus luteum development and function.
|
Endocrine
|
2002
|
0.86
|
31
|
The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action.
|
Angiogenesis
|
2012
|
0.85
|
32
|
Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
|
Fertil Steril
|
2011
|
0.84
|
33
|
Broad spectrum antiangiogenic treatment for ocular neovascular diseases.
|
PLoS One
|
2010
|
0.84
|
34
|
The albino mutation of tyrosinase alters ocular angiogenic responsiveness.
|
Angiogenesis
|
2013
|
0.81
|
35
|
A morphometric study of mechanotransductively induced dermal neovascularization.
|
Plast Reconstr Surg
|
2011
|
0.81
|
36
|
Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.
|
Angiogenesis
|
2013
|
0.80
|
37
|
Common polymorphisms in angiogenesis.
|
Cold Spring Harb Perspect Med
|
2012
|
0.78
|
38
|
Suppression of autoimmune retinal inflammation by an antiangiogenic drug.
|
PLoS One
|
2013
|
0.77
|
39
|
X-linked dominant growth suppression of transplanted tumors in C57BL/6J-scid mice.
|
Cancer Res
|
2005
|
0.75
|